Literature DB >> 18577695

Eliminating phosphorylation sites of the parathyroid hormone receptor type 1 differentially affects stimulation of phospholipase C and receptor internalization.

Susanne U Miedlich1, Abdul B Abou-Samra.   

Abstract

The parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor (PTH1R) belongs to family B of seven-transmembrane-spanning receptors and is activated by PTH and PTHrP. Upon PTH stimulation, the rat PTH1R becomes phosphorylated at seven serine residues. Elimination of all PTH1R phosphorylation sites results in prolonged cAMP accumulation and impaired internalization in stably transfected LLC-PK1 cells. The present study explores the role of individual PTH1R phosphorylation sites in PTH1R signaling through phospholipase C, agonist-dependent receptor internalization, and regulation by G protein-coupled receptor kinases. By means of transiently transfected COS-7 cells, we demonstrate that the phosphorylation-deficient (pd) PTH1R confers dramatically enhanced coupling to G(q/11) proteins upon PTH stimulation predominantly caused by elimination of Ser(491/492/493), Ser(501), or Ser(504). Reportedly, impaired internalization of the pd PTH1R, however, is not dependent on a specific phosphorylation site. In addition, we show that G protein-coupled receptor kinase 2 interferes with pd PTH1R signaling to G(q/11) proteins at least partially by direct binding to G(q/11) proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577695      PMCID: PMC2536737          DOI: 10.1152/ajpendo.00036.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  40 in total

1.  Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-P(i) cotransporter.

Authors:  M Traebert; H Völkl; J Biber; H Murer; B Kaissling
Journal:  Am J Physiol Renal Physiol       Date:  2000-05

2.  The N-terminal region of the third intracellular loop of the parathyroid hormone (PTH)/PTH-related peptide receptor is critical for coupling to cAMP and inositol phosphate/Ca2+ signal transduction pathways.

Authors:  Z Huang; Y Chen; S Pratt; T H Chen; T Bambino; R A Nissenson; D M Shoback
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

3.  Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity.

Authors:  N J Freedman; A S Ament; M Oppermann; R H Stoffel; S T Exum; R J Lefkowitz
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

4.  Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity.

Authors:  A Iida-Klein; J Guo; M Takemura; M T Drake; J T Potts; A Abou-Samra; F R Bringhurst; G V Segre
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

5.  Functional characterization of five constitutively activating thyrotrophin receptor mutations.

Authors:  P Wonerow; S Chey; D Führer; H P Holzapfel; R Paschke
Journal:  Clin Endocrinol (Oxf)       Date:  2000-10       Impact factor: 3.478

6.  PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.

Authors:  B Lanske; A C Karaplis; K Lee; A Luz; A Vortkamp; A Pirro; M Karperien; L H Defize; C Ho; R C Mulligan; A B Abou-Samra; H Jüppner; G V Segre; H M Kronenberg
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

7.  Parathyroid hormone (PTH)/PTH-related peptide receptor density modulates activation of phospholipase C and phosphate transport by PTH in LLC-PK1 cells.

Authors:  J Guo; A Iida-Klein; X Huang; A B Abou-Samra; G V Segre; F R Bringhurst
Journal:  Endocrinology       Date:  1995-09       Impact factor: 4.736

8.  A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor.

Authors:  G Kong; R Penn; J L Benovic
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

9.  Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

Authors:  A C Karaplis; A Luz; J Glowacki; R T Bronson; V L Tybulewicz; H M Kronenberg; R C Mulligan
Journal:  Genes Dev       Date:  1994-02-01       Impact factor: 11.361

10.  Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation.

Authors:  N Amizuka; H Warshawsky; J E Henderson; D Goltzman; A C Karaplis
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

View more
  6 in total

1.  Disruption of parathyroid hormone and parathyroid hormone-related peptide receptor phosphorylation prolongs ERK1/2 MAPK activation and enhances c-fos expression.

Authors:  Hesham A Tawfeek; Abdul B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-13       Impact factor: 4.310

Review 2.  Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.

Authors:  Jean-Pierre Vilardaga; Guillermo Romero; Peter A Friedman; Thomas J Gardella
Journal:  Cell Mol Life Sci       Date:  2010-08-12       Impact factor: 9.261

3.  Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics.

Authors:  Grace R Williams; Jennifer R Bethard; Mary N Berkaw; Alexis K Nagel; Louis M Luttrell; Lauren E Ball
Journal:  Methods       Date:  2015-07-06       Impact factor: 3.608

4.  Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting.

Authors:  Verónica Alonso; Clara E Magyar; Bin Wang; Alessandro Bisello; Peter A Friedman
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

Review 5.  PTH and PTHrP signaling in osteoblasts.

Authors:  Nabanita S Datta; Abdul B Abou-Samra
Journal:  Cell Signal       Date:  2009-02-26       Impact factor: 4.315

6.  Novel mutations in PTH1R associated with primary failure of eruption and osteoarthritis.

Authors:  S A Frazier-Bowers; H M Hendricks; J T Wright; J Lee; K Long; C F Dibble; S Bencharit
Journal:  J Dent Res       Date:  2013-12-03       Impact factor: 6.116

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.